New Drug Approved For Postmenopausal Pain During Sex

Diane S. Aschenbrenner
In: AJN, American Journal of Nursing · 2013 · vol. 113(6) , pp. 24 · doi:10.1097/01.naj.0000431265.70708.6a · W2045834072
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-17 ⓘ

Ospemifene is a new drug approved for postmenopausal dyspareunia, but it carries risks of endometrial cancer, endometriosis, stroke, and deep vein thrombosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ospemifene (Osphena) is a new drug for postmenopausal women who suffer from painful intercourse (dyspareunia). The drug has estrogen agonist effects in the endometrium that increase the risks of endometriosis and endometrial cancer; estrogen antagonist effects elsewhere in the body increase the risk of thrombotic stroke and deep vein thrombosis.

My notes (saved in your browser only)

Condition tags

endometriosisdyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-05-20T11:00:21.680559+00:00
License: CC0 · commercial use OK